Haoxi Health Technology Limited HAO
Company Overview
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Why Investors Should Care
Net profit has compounded at 129.8% per year over the last five years.
Revenue has grown at a 73.3% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.10.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue +41.2%, earnings +33.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 73.3%, profit CAGR 129.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 73.29% |
| 1 Year: | 41.20% |
Compounded Profit Growth
| 5 Years: | 129.80% |
| 1 Year: | 33.20% |
Stock Price Performance
| 1 Year: | -97.76% |
| 6 Months: | -99.88% |
| 3 Months: | -82.24% |
| 1 Month: | +10.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)21.90 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 73.3% over 5 years.
- Profit CAGR of 129.8% over 5 years.
CONS
- Trading 99.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 22 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Communication Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HAO Haoxi Health Technology Limited | 3.41 | -0.01 | $1.19M | 0.00% | 14.75% | -15.98% | 73.29% | 129.80% |
| 2 | GOOGL Alphabet Inc. NDXSPXR3KAITECH | 338.36 | 16.97 | $1.99T | 0.25% | 26.20% | 48.68% | 17.96% | 21.53% |
| 3 | META Meta Platforms, Inc. NDXSPXR3KAITECH | 613.48 | 23.12 | $1.35T | 0.31% | 25.69% | 29.85% | 19.89% | 37.61% |
| 4 | NFLX Netflix, Inc. NDXSPXR3KAI | 76.77 | 24.14 | $319.67B | 0.00% | 29.87% | 49.54% | 22.30% | 32.79% |
| 5 | VZ Verizon Communications Inc. SPXR3K | 50.41 | 13.13 | $209.44B | 5.86% | 8.56% | 15.84% | 2.33% | 6.90% |
| 6 | TMUS T-Mobile US, Inc. NDXSPXR3K | 181.69 | 19.03 | $194.89B | 2.45% | 9.39% | 17.99% | 22.63% | 28.77% |
| 7 | DIS The Walt Disney Company SPXR3K | 105.06 | 21.66 | $181.41B | 1.43% | 10.74% | 8.01% | 6.96% | 4.12% |
| 8 | T AT&T Inc. SPXR3K | 25.60 | 8.45 | $175.42B | 4.37% | 6.59% | 18.34% | 0.31% | 3.44% |
| 9 | SPOT Spotify Technology S.A. R3KAITECH | 528.64 | 28.81 | $108.70B | 0.00% | 24.61% | 44.48% | 13.59% | - |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 16.16M | 28.23M | 48.52M | - |
| Cost of Revenue | 15.51M | 26.17M | 45.77M | - |
| Gross Profit | 648.72K | 2.06M | 2.75M | - |
| Operating Expenses | 379.95K | 866.25K | 1.03M | - |
| Operating Income | 268.77K | 1.20M | 1.72M | - |
| EBITDA | 271.77K | 1.22M | 1.79M | - |
| Interest Expense | 9.96K | 20.90K | 41.19K | - |
| Pretax Income | 259.60K | 1.19M | 1.74M | - |
| Tax Provision | 15.01K | 220.65K | 443.58K | - |
| Net Income | 244.59K | 969.75K | 1.29M | - |
| Diluted EPS | 17.89 | 111.36 | 135.68 | 168.96 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 542.99K | 4.46M | 15.51M | - |
| Current Assets | 445.06K | 3.67M | 15.38M | - |
| Cash & Equivalents | 293.51K | 1.20M | 6.66M | - |
| Inventory | - | - | - | - |
| Receivables | 3.92K | 7.75K | 226.75K | - |
| Total Liabilities | 2.01M | 2.90M | 4.23M | - |
| Current Liabilities | 2.01M | 2.58M | 3.87M | - |
| Long Term Debt | - | 249.11K | 368.04K | - |
| Total Debt | 505.40K | 850.06K | 1.20M | - |
| Total Equity | -1.47M | 1.57M | 11.27M | - |
| Shares Outstanding | 9.96K | 9.96K | 10.07K | 22.63K |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Operating Cash Flow | -675.36K | -872.13K | -747.58K |
| Investing Cash Flow | -8.70K | -45.50K | -3.13M |
| Financing Cash Flow | 933.22K | 1.80M | 9.32M |
| Capital Expenditure | -8.70K | -45.50K | -55.37K |
| Free Cash Flow | -684.06K | -917.63K | -802.94K |
| Net Change in Cash | 249.16K | 884.94K | 5.45M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | 4.0% | 7.3% | 5.7% | - |
| Operating Margin % | 1.7% | 4.2% | 3.5% | - |
| Net Margin % | 1.5% | 3.4% | 2.7% | - |
| ROE % | -16.7% | 61.9% | 11.5% | - |
| ROCE % | -18.3% | 63.3% | 14.8% | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Marex Group Ltd. | 0.32% | 1.90K | $5.46K |
| 2 | Virtu Financial LLC | 0.10% | 581 | $1.67K |
| 3 | Xtx Topco Ltd | 0.09% | 537 | $1.54K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HAO
HAO Stock Price, Quote & Chart - ChartMill
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE1SRGlDTkxDWDRPODBxdzg5cXRCR25LTXdnSi1qcTdDbTNPQkkxM0tsVXlINFJkdTNzb1BxamlmZzZubllFUkd0cjhEaURhdWFCa3NLcDJFcXNHczRjYUE?oc=5" target="_blank">HAO Stock Price, Quote & Chart</a> …
HAO Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBOWDVZQXhKTDZzMFplcTFLOVVTZ3BRNEdJRXVCb28zYkh4V2Rxdzd0OVZFTjZud015YW1jdDJKZ2lmYllZN3hWTGtxTVQxWDJlbzY3Y2Q5UVR6dl84?oc=5" target="_blank">HAO Should I Buy</a> <font color…
Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxORllLYVUwTC03bG96eWNPWUZ2OVJVQU1faXo1ZjE2M1ZhRmtXQzB5U3duQi15X1NiR1RqQ25nUXItcVktRlBEZExmTDZMbzdrNkVXT2txTS1UM3ppUENZQkZPQi14VnpWNUZtWWZkcEtaRUtvSkV5S1p5MWVzQV9vNXNFZF9DVHR2NGVaaF…
Haoxi Health (NASDAQ: HAO) approves par value drop to $0.0000001 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQYUZOeXgtRjl5blBOcHNwSVMtT3hRYXotTEkwVDNVb1d6bzFpWWRETGY4b1YwV2JSbHF4blJwZnNnczYyU2JzRjdZVnUtUDlqRlJrNjBCZWV1X0U5ZFhCVnJHc3ItZDAtT25ibjgyR2FUQ0NlaWx3VzFzWk9CVk96UFhwREJGc0VJVDZjT3…
$HAO stock is up 35% today. Here's what we see in our data. | HAO Stock News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNYUUydXFtWjZjbXhEV0Mtd043OGtwZ0hHRjJOaFplbWFieUxIdk9IVnI2Ym9lTFI3VHA0R2Z6NUxlb3hIeG5Xc3NTVU5UYTc0TTdrOWRvN2hGT1NoeHo0cUNfZWQ5enA0d3hoekVfLVpJLUN6bG5nTzA5dVBFYmpXWDdXVVI1d0JwQ09qTG…
HAO - Finviz
<a href="https://news.google.com/rss/articles/CBMiREFVX3lxTFBUdWxtZWNHcEFfbG50UW5uaGoxd3hVb3NjdVhZaGVVUlVrcFV6X0JwNlo1UTlzamRuZ25xbjhSR19kbHg4?oc=5" target="_blank">HAO</a> <font color="#6f6f6f">Finviz</font>…
HAO — Frequently Asked Questions
What is the current share price of Haoxi Health Technology Limited (HAO)?
As of 2026-09-19 21:16 PDT, Haoxi Health Technology Limited (HAO) trades at $3.41 on NasdaqCM. Its 52-week range is $2.96 to $4,096.00.
What is the market capitalisation of HAO?
Haoxi Health Technology Limited (HAO) has a market capitalisation of $1.19M on NasdaqCM.
What is the P/E ratio of HAO?
HAO trades at a trailing price-to-earnings (P/E) ratio of -0.01. The industry average P/E is 16.99. Its price-to-book (P/B) ratio is 0.00.
What is the return on equity (ROE) of HAO?
HAO has a return on equity (ROE) of -15.98%. Its return on capital employed (ROCE) is 14.75%.
Is HAO a good stock to buy?
This page provides a data-driven analysis of Haoxi Health Technology Limited (HAO), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.